- Home
- OXM vs XNCR Comparison
OXM vs XNCR Comparison
Compare OXM & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXM
- XNCR
- Stock Information
- Founded
- OXM 1942
- XNCR 1997
- Country
- OXM United States
- XNCR United States
- Employees
- OXM N/A
- XNCR N/A
- Industry
- OXM Apparel
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- OXM Consumer Discretionary
- XNCR Health Care
- Exchange
- OXM Nasdaq
- XNCR Nasdaq
- Market Cap
- OXM 672.2M
- XNCR 579.3M
- IPO Year
- OXM N/A
- XNCR 2013
- Fundamental
- Price
- OXM $41.17
- XNCR $8.54
- Analyst Decision
- OXM Hold
- XNCR Buy
- Analyst Count
- OXM 6
- XNCR 7
- Target Price
- OXM $55.80
- XNCR $27.50
- AVG Volume (30 Days)
- OXM 510.6K
- XNCR 791.6K
- Earning Date
- OXM 06-11-2025
- XNCR 08-04-2025
- Dividend Yield
- OXM 6.69%
- XNCR N/A
- EPS Growth
- OXM 100.54
- XNCR N/A
- EPS
- OXM 5.14
- XNCR N/A
- Revenue
- OXM $1,511,278,000.00
- XNCR $127,228,000.00
- Revenue This Year
- OXM $0.49
- XNCR N/A
- Revenue Next Year
- OXM $1.90
- XNCR $28.84
- P/E Ratio
- OXM $8.03
- XNCR N/A
- Revenue Growth
- OXM N/A
- XNCR N/A
- 52 Week Low
- OXM $38.74
- XNCR $7.16
- 52 Week High
- OXM $108.51
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- OXM 30.89
- XNCR 44.94
- Support Level
- OXM $40.46
- XNCR $8.05
- Resistance Level
- OXM $43.00
- XNCR $10.20
- Average True Range (ATR)
- OXM 2.58
- XNCR 0.57
- MACD
- OXM -1.40
- XNCR -0.01
- Stochastic Oscillator
- OXM 13.77
- XNCR 31.40
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.